A Prospective Cohort Study of Compound Nanxing Zhitong Ointment

NCT05201365 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2022-01-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and the efficacy of compound Nanxing pain relief cream in the treatment of chronic pain in the musculoskeletal system

Conditions

  • Chronic Musculoskeletal Pain

Sponsors & Collaborators

  • Jiangsu Kanion Pharmaceutical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • chen weiheng, M.D. · Vice President of the Third Affiliated Hospital of Beijing University of Chinese Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2023-01-31
Completion
2024-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201365 on ClinicalTrials.gov